Low molecular weight heparins

被引：2

作者：

vonTempelhoff, GF ^{[1
]}

Wolf, H ^{[1
]}

Herrle, B ^{[1
]}

Hojnacki, B ^{[1
]}

Heilmann, L ^{[1
]}

机构：

[1] UNIV MAINZ,TEACHING HOSP,D-6500 MAINZ,GERMANY

来源：

关键词：

D O I：

10.1177/107602969600200412

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：292 / 293

页数：2

共 50 条

[41] LIMITATIONS OF LOW-MOLECULAR-WEIGHT HEPARINS
PRIOLLET, P
ALHENCGELAS, M
AIACH, M
SEMAINE DES HOPITAUX, 1991, 67 (40-41): : 1806 - 1808
[42] Preclinical differentiation of low molecular weight heparins
Nader, HB
Walenga, JM
Berkowitz, SC
Ofosu, F
Hoppensteadt, DA
Cella, G
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 : 63 - 72
[43] Human pharmacokinetics of low molecular weight heparins
Cornelli, U
Fareed, J
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 : 57 - 61
[44] Clinical trials of low molecular weight heparins
Turpie, AGG
EUROPEAN HEART JOURNAL SUPPLEMENTS, 1999, 1 (0R) : R18 - R27
[45] Low molecular weight heparins: Background and pharmacology
Morris, TA
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 21 (06) : 537 - 546
[46] HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS
HIRSH, J
CORONARY ARTERY DISEASE, 1992, 3 (11) : 990 - 1002
[47] Arterial indications for the low molecular weight heparins
Ageno, W
Huisman, MV
CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2001, 2 (05): : 233 - 239
[48] Clinical differentiation of low molecular weight heparins
Mammen, BF
Arcelus, J
Messmore, H
Altman, R
Nurmohamed, M
Eldor, A
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 : 135 - 144
[49] Development and perspectives of low molecular weight heparins
Lockner, D
PHLEBOLOGIE, 1999, 28 (02) : 45 - 47
[50] Formulary management of low molecular weight heparins
Wade, WE
Martin, BC
Kotzan, JA
Spruill, WJ
Chisoholm, MA
Perri, M
PHARMACOECONOMICS, 2000, 17 (01) : 1 - 12